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Frizzled receptors have seven membrane-spanning helices and are considered as atypical G protein-coupled receptors (GPCRs).
The mating response of the yeast Saccharomyces cerevisiae is mediated by a GPCR signaling system and this model organism
has been used extensively in the past to study mammalian GPCR function. We show here that human Frizzled receptors (Fz1
and Fz2) can be properly targeted to the yeast plasma membrane, and that they stimulate the yeast mating pathway in the
absence of added Wnt ligands, as evidenced by cell cycle arrest in G1 and reporter gene expression dependent on the mating
pathway-activated FUS1 gene. Introducing intracellular portions of Frizzled receptors into the Ste2p backbone resulted in the
generation of constitutively active receptor chimeras that retained mating factor responsiveness. Introducing intracellular
portions of Ste2p into the Frizzled receptor backbone was found to strongly enhance mating pathway activation as compared
to the native Frizzleds, likely by facilitating interaction with the yeast Ga protein Gpa1p. Furthermore, we show reversibility of
the highly penetrant G1-phase arrests exerted by the receptor chimeras by deletion of the mating pathway effector FAR1. Our
data demonstrate that Frizzled receptors can functionally replace mating factor receptors in yeast and offer an experimental
system to study modulators of Frizzled receptors.
Citation: Dirnberger D, Seuwen K (2007) Signaling of Human Frizzled Receptors to the Mating Pathway in Yeast. PLoS ONE 2(9): e954. doi:10.1371/
journal.pone.0000954
INTRODUCTION
The mammalian Wnt proteins are secreted lipid-modified
signaling molecules which control aspects of embryonic de-
velopment. In the adult, Wnts have a role in diseases such as
cancer, osteoporosis, and psychiatric disorders (reviewed in [1,2]).
Wnts function via receptor-mediated signaling pathways including
members of the Frizzled (Fz) gene family.
Frizzled receptors share the basic structural organization of G
protein-coupled receptors (GPCRs) with seven transmembrane-
spanning domains, and exhibit a complex N-glycosylated exofacial
N-terminal region. With regard to signal transduction, the majority
of literature has dealt with the so called canonical signaling pathway
which is quite divergent from classical GPCR signaling. In the
canonical pathway, the phosphoprotein Dishevelled (Dv1) inhibits
glycogen synthase kinase 3-b (GSK3b) leading to stabilization and
nuclear translocation of the b-catenin protein and transcription of
specific response genes (for a recent review see [3]).
Interestingly, there is also evidence that Frizzled receptors can
exert functions independently of b-catenin. These phenomena
were called ‘noncanonical’ Wnt-Fz signaling and common features
with classical GPCR signal transduction were described (reviewed
in[4,5]). This includessensitivity of Wnt-stimulated calcium flux and
other signaling events to pertussis toxin, a specific inhibitor of G
proteins of the Gi-class. Furthermore, Wnt-11-stimulated Rho
GTPase activity was shown to depend on Gbc signaling. Frizzled
receptors were also described to couple to the visual G protein
transducin (Gt). Dishevelled was found to recruit b-arrestin, a known
modulator of GPCR function, to regulate Wnt5A/Fz4 signaling in
human cultured cells [6]. Some reports also implicated hetero-
trimeric G proteins in canonical signaling stimulated by rat Frizzled-
1 (Rfz1) [7,8]. Strong evidence in this direction was also reported in
Drosophila,wheregeneticexperimentsrevealedthatGaowasrequired
totransducebothcanonicaland non-canonicalsignals[9].However,
a direct role of Frizzled receptors as GDP-GTP exchange factors for
Ga proteins has not yet been demonstrated.
Key principles of GPCR signaling have been unraveled using
yeast as a model system. This includes the genetic demonstration
of signaling through Gbc proteins, as well as the identification of
the first member of the regulator-of-G protein-signaling (RGS)
class of Ga GTPase activators, termed Sst2p [10]. In yeast,
GPCRs control the mating pathway that is used for sexual
reproduction (reviewed in [11]). When haploid cells of mating type
a and a meet, they extend a projection toward the other
(‘‘shmoo’’), stop their cell cycle, start transcription of mating
genes, and finally fuse to form a diploid cell. The mating process
involves specific signaling proteins such as secreted pheromones (a
and a-factor), GPCR-class pheromone receptors (Ste2p and
Ste3p), a heterotrimeric G protein (Gabc), a Gbc - activated
MAP kinase cascade leading to expression of pheromone-
responsive genes, and growth arrest via CDK-inhibition (Fig. 1).
The first report demonstrating functional coupling of a heterol-
ogous GPCR to the yeast mating pathway, i.e. human b2-
adrenergic receptor, suggested a significant conservation of the
GPCR-machineries of mammalian and yeast cells [12].
In the present work we aimed to use the particular advantages
of the yeast mating pathway system to study human Frizzled
receptors. Support for this approach recently came from the whole
genome sequence analysis of the social amoeba Dictyostelium
discoideum, which identified predicted receptors of the frizzled/
smoothened class (family 5) in this organism. Previously, such
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Dictyostelium represents an evolutionary older organism than yeast,
Frizzleds may be considered as archetypic receptors, suggesting
that they may be compatible with the yeast GPCR- machinery.
We show that both human Frizzled1 and Frizzled2, considered
as canonical and noncanonical receptors, respectively, can signal
to the yeast mating pathway in the absence of added ligand.
Overexpression of Frizzled receptors leads to increased accumu-
lation of cells in the G1 phase of the cell cycle, a feature of the
activated mating pathway, and activation of a specific mating
pathway reporter. We devised specific receptor chimeras between
Frizzleds and the yeast a-factor receptor Ste2p for pharmacolog-
ical studies with Wnt-ligands and a-factor pheromone, and identify
chimeras mediating highly penetrant G1-phase arrests. These
effects are partially reversible by deletion of the mating pathway
effector gene FAR1 [14].
RESULTS
Expression of human Frizzled receptors in yeast
A previous study, using a topology-sensitive reporter, suggested
that the Drosophila Frizzled receptor expressed in yeast has the
structure of a seven-pass transmembrane protein [15]. We first
explored the feasibility to express human Fz1 in a yeast wildtype
strain by a related approach: We took advantage of the nutritional
reporter Ura3p fused to the C-terminus of Fz1 as shown in Fig. 2A.
The URA3 gene encodes orotidine-59-phosphate decarboxylase
which functions in the biosynthesis of pyrimidines in the cytosol.
Used as a fusion tag it provides information on the fate of the
tagged protein. Absence of growth on minimal media lacking
uracil indicates insufficient cytosolic Ura3p levels, which may
result from improper protein synthesis or transport. Yeast
expressing our initial Fz1-Ura3p construct failed to grow in the
absence of uracil (Fig. 2A, top), and we reasoned that this might be
the result of improper targeting of the protein to the yeast
secretory pathway. To circumvent potential problems with the N-
terminal sorting information of the mammalian Fz1, we devised
a chimeric receptor consisting of human Fz1 with the amino acids
N-terminal to the cysteine-rich domain (CRD) replaced with the
extracellular N-terminal tail from the yeast a-factor receptor Ste2p
(termed signal sequence ‘‘s’’ in the following). This design was
chosen to preserve the Wnt-ligand binding region that is attributed
to the CRD, a characteristic feature of Frizzled receptors [16].
As shown in Fig. 2A (bottom), the growth assay using Ura3p
fused to the C-terminus of the s-Fz1 chimeric receptor indicates
good expression - colony numbers and growth rates are
comparable to the control plate. This is consistent with proper
membrane insertion of the receptor with the Ura3p moiety facing
the cytosolic space.
In order to further clarify the subcellular localization of the s-
Fz1 receptor, we fused enhanced green fluorescent protein (eGFP)
to the receptor’s C-terminus to be able to monitor expression using
confocal microscopy. As shown in Fig. 2B, we found a pronounced
plasma membrane rim-like GFP signal, as well as apparently
perinuclear staining which is similar to the localization described
previously for GFP-tagged Ste2p [17].
In Western blot analysis using a myc-tagged version of the s-Fz1
receptor we obtained a signal of expected size (60 kDa). The broad
appearance of the band points to the glycosylated status of the
protein, which is a frequent modification of serpentine receptors
(Fig. 2B).
In addition to the ‘canonical’ Frizzled 1 receptor, we were
interested in studying the ‘noncanonical’ Frizzled 2 receptor in the
yeast system. We constructed the s-Fz2 receptor construct in
analogy to s-Fz1 as depicted in Fig. 2C. Both receptors showed
similar functionality in yeast (see below).
Growth modulatory effects and activation of
a mating pathway reporter system
In growth experiments with wildtype yeast, we consistently found
that the overexpression of both s-Fz1 and s-Fz2 receptors in
a galactose-inducible system (GAL1 promoter) leads to a weak but
significant growth inhibition (Fig. 3A). Absence of such effects
using overexpressed Ste2p, or the human Edg2 receptor, that is
known to couple to Gpa1p in yeast [18], indicates the specificity of
the Frizzled-mediated growth inhibition (Fig. 3A). Mating
pathway activation by a-factor induced growth arrest occured as
expected (Fig. 3A, right panel).
We next set out to confirm the basal activities of s-Fz1/2
observed in the growth modulation assays using a specific mating
pathway reporter system. This system employs a firefly luciferase
reporter gene under the control of the pheromone-responsive
FUS1 promoter (PFUS1-luciferase; Fig. 1). We used this reporter
construct in a specifically engineered yeast strain background that
carries a gpa1 allele (termed MC18; [19]). The system allows the
use of plasmid - encoded heterologous Ga proteins to replace the
yeast Ga Gpa1p. In the absence of exogenous Gpa1p this strain
shows constitutive mating pathway activation, and we call it ‘‘ON’’
strain in the following. Conversely, expression of Gpa1p in the
Figure 1. Schematic representation of the GPCR-controlled mating
pathway in S. cerevisiae. Shown is the situation for mating type
a haploid yeast cells. Cells normally express the a-factor receptor Ste2p
– Frizzled receptors are introduced by ectopic expression. Ste2p
activation through its ligand a-factor leads to GDP-GTP exchange in the
Ga protein Gpa1p, and dissociation of the heterotrimeric G protein. The
resulting free bc subunits trigger activation of a MAP kinase cascade
leading to the transcription of pheromone-responsive genes such as
FUS1, as well as to G1 growth arrest via inhibition of the cyclin-
dependent kinase inhibitor FAR1 gene product. A mating pathway
activation growth assay using wildtype yeast cells (MH272-1da) is
shown bottom left. The strain was spotted in serial dilutions (,1E4, 1E3,
1E2, 1E1 cells in duplicate) onto complete minimal medium, and treated
with 1 mg a-factor spotted directly onto the yeast patches as indicated.
doi:10.1371/journal.pone.0000954.g001
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pathway (‘‘OFF’’ strain). Previously, the MC18 system was used
successfully to study the coupling of olfactory GPCRs to the
mating pathway [20,21]. For the present study we introduced two
additional deletions into the MC18 strain background: We first
carried out a STE2 deletion to be able to test pathway activation
independently of the endogenous Ste2 receptor (termed MC18
ste2), and secondly we introduced a deletion of the negative
pathway regulator SST2 (MC18 ste2 sst2) in order to obtain
a potentially more sensitive strain ([10]; shown schematically in
Fig. 1).
We used the PFUS1-luciferase reporter system to determine the
mating pathway activation status following overexpression of the
Frizzled proteins in absence of added ligand. To this end, reporter
gene activity was determined under conditions of glucose-
repression and galactose-induction. As shown in Fig. 4, both s-
Fz1 and s-Fz2 display significant inducible activity over the OFF-
strain. The three to four - fold induction levels observed are
comparable to peak-signaling levels for the a-factor - activated
Ste2-receptor (Fig. 4). Overexpression of the Ste2 or Edg2
receptors alone does not raise the signal significantly, again
demonstrating specificity of action of the Frizzled receptors. For
the GPA1-deficient ON-strain an approximately 5-fold induction
over the OFF-strain is observed, as expected. This is consistent
with peak bc signaling in absence of any Gpa1p. In conclusion,
these data are in line with the observations in the growth
modulation assays and demonstrate signaling of the s-Fz1 and s-
Fz2 receptors to the yeast mating pathway.
We were unable to demonstrate further activation of the mating
pathway with commercially available bioactive recombinant
Wnt3a and Wnt5a (data not shown). This may be due to the
lack of appropriate co-receptors in yeast, or the inability of these
ligands to pass through the cell wall (see discussion).
Receptor chimeras between Ste2p and Frizzled 1 or
Frizzled 2
In analogy to work performed previously [7,22] we set out to
engineer two types of chimeras between the yeast Ste2 receptor
and the human Frizzled proteins. First we replaced predicted
intracellular amino acids of Ste2 with corresponding fragments of
Frizzled receptors, with the aim to demonstrate that the Frizzled
Figure 2. Expression strategy and expression tests for human Frizzled
receptors in yeast. A. Expression growth test for Fz1 using the
nutritional reporter Ura3p. Schematically shown as two-dimensional
snake-plots are Fz1, or Fz1 with the N-terminal signal sequence (s) of
the a-factor receptor Ste2p fused upstream of the cysteine-rich-domain
(CRD), and carrying a C-terminal Ura3p reporter. The constructs were
used to transform URA3-deficient yeast cells, and plated equally onto
control plates (C) and minimal medium plates lacking uracil (-U). B.
Subcellular localization and Western blot analysis. The upper panel
shows a confocal micrograph and the corresponsing bright field view of
s-Fz1-GFP expressing yeast cells immobilized by agarose-embedding.
The lower panel shows the Western blot analysis using s-Fz1-myc
expressing yeast cells. Following galactose-induction, crude protein
extracts were prepared and resolved on a 4–12% gradient SDS-PAGE
system. Detection was performed using an anti-c-myc monoclonal
antibody-peroxidase conjugate. Molecular weight standards in kDa are
indicated. The control extract was derived from a yeast strain
transformed with the empty expression vector. C. The s-Fz2 construct
for the expression of human Frizzled 2 was analogous to s-Fz1.
doi:10.1371/journal.pone.0000954.g002
Figure 3. Growth modulation assay of wildtype yeast cells (MH272-
1a) overexpressing human Frizzled receptors and receptor chimeras.
s-Fz1 and s-Fz2 (panel A) as well as receptor chimeras with the Ste2
receptor (B and C) were expressed in a galactose-inducible system, and
effects were compared to a-factor mediated growth arrest. Correspond-
ing receptor schemes are shown in Fig. 2 and Fig. 5. Yeast strains
transformed with plasmid constructs as indicated were pre-cultured in
glucose-containing minimal medium (repressed), and spotted in serial
dilutions (,1E4, 1E3, 1E2, 1E1 cells) onto glucose- or galactose-
(induced) containing minimal medium agar plates selective for the
presence of the plasmid. Growth effects were recorded after 4 and 7
days. Controls were the empty expression vector and Ste2 and Edg2
receptors. The a-factor - mediated growth arrest assay (right panel) was
done using wildtype yeast cells (MH272-1da), as well as isogenic ste2
cells, treated with 1 mg a-factor spotted directly onto the yeast patches
as indicated.
doi:10.1371/journal.pone.0000954.g003
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hoped to retain responsiveness of these constructs to a-factor.
Conversely, by introducing intracellular Ste2 loops into the
Frizzled backbone, we aimed to increase the functional coupling
of the Frizzled receptors to Gpa1p. The receptor chimeras are
shown in Fig. 5, and the nucleotide and amino acid sequences of
the fully synthetic genes are shown in the Supporting Information
section of this article (Text S1). The underlying transmembrane
region assignments for the Fz1, Fz2 and Ste2 receptors (Fig. 6)
were derived by receptor homology-modeling.
The first constructs were named Ste2-Fz1(i) and Ste2-Fz2(i),
respectively, with ‘‘(i)’’ designating the intracellular portions of the
Frizzled receptors. The inverse constructs are named s-Fz1-Ste2(i)
and s-Fz2-Ste2(i), respectively.
First we tested the expression and subcellular localization of
chimeras by fusing GFP to the C-termini. Confocal microscopy
demonstrated the expected plasma membrane localization similar
to s-Fz1-GFP (Fig. 5A), supporting the validity of the homology
models employed to design the constructs. In Western blot analysis
using myc-tagged versions of the chimeras we observed signals of
expected size (both ,37 kDa; Fig. 7). The expression level of the
Ste2p receptor, and the Ste2 - Frizzled 1/2 receptor chimeras
expressed from the codon-optimized synthetic genes were slightly
higher than for the natural human genes s-Fz1/2 and Edg2.
However, the Ste2p overexpression demonstrates that high protein
levels alone do not translate into a growth phenotype.
Interestingly, in growth experiments (Fig. 3B), the Ste2-Fz1/2(i)
receptor chimeras exerted strong growth arrest in the absence of
added a-factor, and the effects were stronger than observed for the
Frizzled constructs described before (s-Fz1/2; Fig. 3A). This
suggests that the intracellular portions of both Fz1 and Fz2 are
able to contact the yeast Ga protein Gpa1p. Indeed, using the
PFUS1-luciferase reporter system we observed significant inducible
activity over the OFF-strain for the overexpressed Ste2-Fz1(i)
receptor, similar to both native s-Fz1 (Fig. 8A), and to a-factor -
activated Ste2-receptor (Fig. 4).
Figure 4. Effect of galactose-inducible overexpression of human
Frizzled receptors (s-Fz1 and s-Fz2) in the PFUS1-luciferase- based
reporter system. Basal activities of s-Fz1 and s-Fz2 in absence of added
ligand were determined. Schemes for receptor constructs used are
shown in Fig. 2. Yeast strain MC18 ste2 sst2 expressing plasmid-encoded
Gpa1p was employed. Crude extracts from glucose-repressed or
galactose-induced yeast strains were assayed in duplicates for luciferase
activity. Normalization was done based on total protein concentration.
Signals are expressed relative to the receptor-deficient ‘‘OFF’’-strain
grown under induced conditions. Ste2p- (treated and untreated with
1 mM a-factor), Edg2-overexpressing strains, as well as the GPA1-
deficient ‘‘ON’’-strain were included as further controls. Bars represent
average+/2range.
doi:10.1371/journal.pone.0000954.g004
Figure 5. Construction schemes and subcellular localization of chimeras between the human Frizzled and S. cerevisiae Ste2 receptors. Receptor
homology modeling was used to predict the transmembrane segments (see Fig. 6). A. This chimera type replaces the predicted intracellular portions
of Ste2p with the corresponding ones of either Fz1 or Fz2, resulting in chimeras termed Ste2-Fz1(i) and Ste2-Fz2(i), respectively, with ‘‘(i)’’ designating
intracellular portions. B. The second chimera type replaces the predicted intracellular portions of the human Frizzled receptors with respective ones
of Ste2p, and uses the signal sequence of Ste2p (‘‘s’’) upstream of the cysteine-rich-domain (CRD) to give rise to s-Fz1-Ste2(i) and s-Fz2-Ste2(i). The
fully synthetic gene sequences and respective amino acid sequences are given in the Supporting Information section of this article (Text S1). The
subcellular localization of constructs tagged C-terminally with GFP is shown in the confocal micrographs.
doi:10.1371/journal.pone.0000954.g005
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still able to respond to a-factor. As is shown in Fig. 8C this is
indeed the case, however, the potency of the response is
significantly lower for these chimeras than for the native Ste2
receptor. In concentration - response experiments we estimated
EC50 values for both Ste2-Fz1/2(i) in the low micromolar range
versus a low nanomolar range for Ste2p, which is in agreement
with literature data [23]. The signals were consistently above those
obtained for the receptor-deficient OFF-strain.
When we tested the s-Fz1/2-Ste2(i) chimeras in the growth
modulation assay, we observed that both receptors of this type
exert a complete growth arrest (Fig. 3C), even more pronounced
than the a-factor response in wild type (Fig. 3A, right panel). This
effect is consistent with the Ste2p-portions mediating contact to the
yeast Ga protein Gpa1p, and acting cooperatively with the
Frizzled receptor backbone to adopt an active conformational
state. Expectedly, upon overexpression of the s-Fz1/2-Ste2(i)
chimeras in a yeast wildtype strain this growth behaviour was
Figure 6. Transmembrane segment predictions for human Fz1, Fz2, and S. cerevisiae Ste2 receptors. The helices one to seven are shown as
amino-acid sequences with indicated position numbers of the full sequence. The predictions were derived by receptor modeling. The
transmembrane region assignment was based on a hydrophobicity analysis followed by manual adjustment of the overlap of some key amino acids
(e.g., W and P in TM4, TM5, and TM6) with those found in rhodopsin and other reference receptors.
doi:10.1371/journal.pone.0000954.g006
Figure 7. Quantification of receptor expression by Western blot.
Following galactose-induction, crude protein extracts were prepared
from the MH272-1da wildtype yeast strain transformed with the
indicated plasmids, and resolved on a 4–12% gradient SDS-PAGE
system. Detection of the myc-tagged receptors was performed using
chromogenic indirect anti-c-myc monoclonal detection. Equal loading
was monitored using a polyclonal anti-Kss1p antibody. The control
extract was derived from a yeast strain transformed with the empty
expression vector. The asterisks indicate the specific signals. Molecular
weight standards in kDa are indicated.
doi:10.1371/journal.pone.0000954.g007
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cerevisiae Ste2 receptor in the PFUS1-luciferase- based reporter system. Yeast strain MC18 ste2 sst2 expressing plasmid-encoded Gpa1p was
employed. Schemes for receptor constructs used are shown in Fig. 5. A. and B. Basal activities of Ste2-Fz1(i) and s-Fz1-Ste2(i) receptors in absence of
added ligand, and comparison to the s-Fz1 overexpressing strain. Crude extracts from glucose-repressed or galactose-induced yeast strains were
assayed in duplicates for luciferase activity after 6 h (A.) or 24 h (B). Normalization was done based on total protein concentration. Signals are
expressed relative to the receptor-deficient ‘‘OFF’’-strain grown under induced conditions. Bars represent means+/2range. C. a-factor concentration -
response in the MC18 ste2 sst2 strain expressing plasmid-encoded Gpa1p and Ste2-Fz1/2(i) receptor chimeras or Ste2p. The galactose-induced yeast
strains were incubated for 4 hours with indicated concentrations of a-factor, and crude extracts were subsequently assayed in quadruplets for
luciferase activity. As negative control served a strain transformed with empty vector (‘‘OFF’’-strain). Responses are expressed as treated/control
values; error bars indicate S.E.M. (N=4).
doi:10.1371/journal.pone.0000954.g008
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the PFUS1-luciferase reporter system, similar to what was observed
for native s-Fz1 and the Ste2-Fz1(i) chimera (Fig. 8A). Peak
signaling levels were as observed for the a-factor - activated Ste2
receptor (Fig. 4).
The PFUS1-luciferase reporter system did not differentiate
quantitatively between the native s-Fz1/2 and chimeric receptor
constructs as observed in the growth assay (compare Fig. 8A and
Fig. 3). Since a major difference between these two experimental
readouts is the time following induction of receptor expression
(6 hours for the PFUS1-luciferase reporter system vs. up to 7 days
for the plate growth assay), we decided to measure PFUS1-luciferase
activity after prolonged incubation (24 hours). In better agreement
with the long-term growth assays, we observed strong persistent
signaling for the chimeric receptors Ste2-Fz1(i) and s-Fz1-Ste2(i)
after 24 hours, whereas the signal for the s-Fz1 construct was
reduced. (Fig. 8B). The reason for this apparently differential
desensitization is not known.
Growth in liquid culture and budding index
Cell cycle arrest following mating pathway activation results in an
‘‘unbudded’’ cellular morphology, and eventually induction of
a ‘‘shmoo’’- morphology prior to diploid formation. Therefore, we
were interested to investigate the morphological changes of a yeast
wildtype strain following galactose-induction of s-Fz1, Ste2-Fz1(i)
or s-Fz1-Ste2(i) receptor expression in liquid culture. For this
purpose, we first monitored the relative growth rates of the strains
grown in repressing or inducing medium. The result was
consistent with the plate growth assay (Fig. 3): In the absence of
receptor expression the three strains grew comparably to the
empty-vector control strain (Fig. 9A). When switched to inducing
medium, following a lag-phase due to adaptation, the strains grew
differentially with the s-Fz1 strain showing significant growth
retardation, and the strains carrying the chimeric receptors
showing almost complete growth arrest. (Fig. 9B). Consistently
with a differential ability of the three receptor constructs to induce
G1 arrest, we determined significantly lowered budding indices
down to ,0.4 for the s-Fz1 strain, ,0.3 for Ste2-Fz1(i) and ,0.2
for s-Fz1-Ste2(i) after 24 hours grown in the inducing medium
(Fig. 9C). Moreover, while the s-Fz1 expressing strain was able to
recover from the G1 arrest after 24 hours, as indicated by an
increased budding index up to ,0.6, the receptor chimeras
appeared to be permanently arrested. This is in agreement with
the reduced PFUS1-luciferase activity measured 24h after receptor
induction (Fig. 8B). Specific G1 arrests we further confirmed by
investigating the nuclear morphologies using staining by 49,6-
diamidino-2-phenylindole (data not shown). However, we did not
observe ‘‘shmoo’’-like shaped cells at any time point upon
overexpression of any of the three receptor classes. This is similar
to previous observations made for constitutively active mutants of
Ste2p that showed only weak induction of projections despite high
PFUS1-reporter levels [24].
Suppression of Frizzled-mediated growth arrest by
deletion of the mating pathway effector FAR1
In order to further exclude growth inhibition by unspecific effects,
we aimed to demonstrate genetically that the growth phenotypes
conveyed by Frizzled expression are dependent on a functional
mating pathway. The FAR1 gene product is required for growth
arrest in the G1 phase of the cell cycle following mating pathway
activation. Inactivation of the FAR1 gene leads to cell cycle
progression despite activated mating pathway through antagoniz-
ing the cyclin Cln2p (Fig. 1) [14]. Therefore, we reasoned that the
Figure 9. Growth behaviour and morphologies of wildtype yeast cells
(MH272-1da) overexpressing galactose-inducible s-Fz1 or receptor
chimeras between Fz1 and Ste2p in liquid culture. Schemes for
receptor constructs used are shown in Fig. 2 and Fig. 5. As control
served a strain transformed with empty vector. Growth curves in
glucose- (repressed; (A)), or galactose-containing (induced; (B.)) minimal
medium, following washout of glucose, as determined using optical
density measurement, or microscopic counting in a hemocytometer
slide at the indicated timepoints, respectively. C. Budding indices (ratio
of budded to total yeast cells) of the induced cultures were determined
using microscopic counting in a hemocytometer slide.
doi:10.1371/journal.pone.0000954.g009
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growth effects seen for the receptor chimeras between Ste2p and
Fz1/2. We created a far1 yeast strain and tested first its
responsiveness to a-factor in a growth assay compared to its parent
wildtype strain, as well as an isogenic ste2 strain (Fig. 10A). The
expected growth arrest is observed for the wildtype strain in the
presence of a-factor, whereas the far1 strain shows the anticipated
progressiontothecellcycle,andunchangedsurvivaluponprolonged
incubation (7 days). The partial suppression of the mating pathway-
induced growth arrest seen in the far1 strain after short incubation (2
days) is consistent with the functional redundancy of Cln2p with the
two other cyclins functional in yeast [14]. Expectedly, the ste2 strain
shows no response to a-factor (Fig. 10A).
The differential growth behavior test of wildtype and far1 strains
overexpressing the Frizzled receptors and respective chimeras with
Ste2p under galactose-induction is shown in Fig. 10B. The empty-
vector control demonstrates that both strains have the same
growth behavior both on glucose- and galactose containing
medium. As anticipated, all three chimeric receptor classes show
a clear gain-of-growth phenotype in the presence of the far1 strain
as compared to the wildtype strain. The only exception is the s-Fz1
receptor, which exerted only very weak growth modulatory effects
in this experiment. The far1 effect is particularly obvious in the
case of the s-Fz1/2-Ste2(i) chimeras, where complete growth arrest
is observed under induced conditions for the wildtype strain. As
expected, no effect of the far1 allele was observed in strains
overexpressing Ste2p. These results confirm that the growth arrest
effects seen for the overexpressed receptor chimeras depend on the
activated mating pathway.
DISCUSSION
Signaling of human Frizzled receptors to the yeast mating pathway
is particularly interesting from the evolutionary perspective: Our
results suggest that the archetypic GPCR signal transduction
machinery of the yeast S. cerevisiae may be related to Frizzled
signaling in animals. It is therefore also conceivable that the
recently identified Frizzled-like receptors in the genome of the
evolutionary older organism Dictyostelium [13] function through
a similar ancestral mechanism.
Previous work has provided some evidence that Frizzled receptors
could act as G protein-coupled receptors [4,5]. However, commonly
usedfunctional testsforGPCRsinmammalian cells (e.g. modulation
of adenylyl cyclase and phospholipase C activities) could not be
applied successfully to Frizzled receptors. In this work, we have
attempted to use yeast as a model organism to study Frizzled
function. We show that overexpressed human Frizzled 1 and
Frizzled 2 receptors partially induce G1 cell cycle arrest in wildtype
yeast cells, a feature of the activated mating pathway, and significant
PFUS1-dependent reporter gene induction.
Specific receptor chimeras between Fz1/2 and the yeast a-
factor receptor Ste2p showed that the predicted intracellular
portions of Fz1/2 are sufficient to signal to the mating pathway if
incorporated into Ste2p, as indicated by a highly penetrant G1 cell
Figure 10. Mating pathway activation growth assay of wildtype yeast cells (MH272-1da), as well as of the isogenic strains carrying far1 or ste2 -
alleles. (A) Yeast strains were spotted in serial dilutions (,1E4, 1E3, 1E2, 1E1 cells in duplicate) onto complete minimal medium, and treated with
1 mg a-factor spotted directly onto the yeast patches. Growth effects were recorded after 2 and 7 days. (B) Comparative growth modulation assay of
wildtype yeast cells (MH272-1a) and respective far1 isogenic strain overexpressing human Frizzled receptors (s-Fz1 and s-Fz2), as well as chimeras
with the S. cerevisiae Ste2 receptor in a galactose-inducible expression system. The corresponding receptor schemes are shown in Fig. 2 and Fig. 5,
respectively. Yeast strains transformed with plasmid constructs as indicated were pre-cultured in glucose-containing minimal medium (repressed),
and spotted in serial dilutions (,1E4, 1E3, 1E2, 1E1 cells) onto glucose- or galactose- (induced) containing minimal medium agar plates selective for
the presence of the plasmid. Growth effects were recorded after 4 to 7 days. Controls were the empty expression vector, as well as overexpressed
Ste2 and Edg2 receptors.
doi:10.1371/journal.pone.0000954.g010
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growth arrest and ability to induce PFUS1-reporter activity seen for
Ste2-Fz1(i) and Ste2-Fz2(i) were almost indistinguishable, which is
in line with the proposed receptor model (Fig. 6): Despite their
different modes of signaling reported in higher eukaryotes
(canonical vs. non-canonical; [25,26], and [22,27,28], respective-
ly), the predicted intracellular portions of Fz1 and Fz2 differ by
only three amino acids. The responsiveness of these chimeras to a-
factor further supports their functionality as GPCRs signaling to
yeast Gpa1p.
Strong growth arrest paralleled with PFUS1-reporter activity was
also observed for the converse receptor chimeras, s-Fz1/2-Ste2(i),
which employ the Ste2-intracellular portions, expected to afford
good coupling to yeast Gpa1p. Overexpressed native Ste2-receptor
does not show any growth effect in the absence of added a-factor,
demonstrating that the Fz1 and Fz2 transmembrane scaffolds allow
the chimeras to adopt a conformationally active state.
Indeed, cooperative action between the transmembrane seg-
ments and connecting loops for establishing the three-dimensional
structure has been described for several GPCRs including Ste2p
[29]: Specific receptor fragments were capable of intragenic allelic
complementation in the absence of a covalent connection of the
transmembrane segments. These data support a two-stage model
of GPCR folding, in which the transmembrane a-helices are first
formed independently, and then are assembled into tertiary
structures.
We were unable to demonstrate Wnt-dependent activation of s-
Fz1/2 receptors, or the s-Fz1/2-Ste2(i) chimeras, in yeast using the
PFUS1-luciferase system. Different reasons may account for this
result. First, the basal activities observed for both receptor classes
were close to the maximal response observed for the a-factor-
activated native Ste2 receptor, hence the response may be already
saturated. On the other hand we observed a-factor responsiveness
of the Ste2-Fz1/2(i) receptor constructs despite similar basal
activity, albeit at significantly lower potency as compared to native
Ste2p. More importantly, at least for the canonical Frizzled 1, the
LRP5/6 co-receptors appear crucial for Wnt ligand binding and
signaling in mammalian cells (reviewed in [3]). Yeast does not
express known co-receptors of this type, such molecules may have
to be supplemented in the heterologous yeast system as well.
Additionally, despite the fact that yeast cells can secrete proteins of
.200 kDa [30], it is generally believed that proteins up to 5–
10 kDa can pass through the cell wall. Consequently, the lipid-
modified Wnt-ligands (approximately 40 kDa) may not pass
through the yeast cell wall to reach the receptors. A possible
solution to this problem may be the use of an autocrine Wnt-Fz
activation system, similarly as described for the autocrine
activation of the C5a receptor through an a-factor prepro/C5a
ligand [31]. Another possible solution would be to examine
spheroplasts or mutants with increased cell wall permeability.
Constitutive activity has been described for many wildtype
GPCRs coupled to Gs-, Gi and Gq-proteins (reviewed in [32]). It is
frequently unmasked by recombinant systems overexpressing
receptors, as is the case in the present study using yeast.
Constitutive activities of GPCRs are also known to depend on
cellular background [32] as cell types may express a different G
protein repertoire and different regulatory proteins. To our
knowledge, constitutive activity of native Frizzled receptors has
not been addressed in the published literature, which is in part due
to a lack of convenient pharmacological tools.
Ste2p receptor oligomerization is thought to promote receptor
biogenesis, G protein signaling and endocytic trafficking [33], and
functionally relevant hetero-oligomerization of GPCRs has been
demonstrated in higher organisms, notably for GABA(B)R1 and
GABA(B)R2 receptor subunits [34]. While it is formally possible
that Ste2 - Fz hetero-oligomerization contributes to the growth
effects seen in wildtype yeast cells, we observed autonomous
constitutive activity of the Frizzled receptor constructs in our
STE2-deficient PFUS1-dependent reporter gene system.
In yeast, genetic screens were used to isolate mutations that
constitutively activate the Ste2p receptor [24,35]. Interestingly,
similar features to the present constitutively active receptors have
been described: This includes the observation that the over-
expressed Ste2-P258L, S259L -mutant receptor shows PFUS1-
reporter levels comparable to the maximal response for a-factor-
activated native Ste2p [24], despite only weak induction of the
expected ‘‘shmoo’’-morphology. This has been attributed to the
potential inability of these constitutively active receptors to
stimulate receptor functions in morphogenesis that are not
mediated by G protein activation [36,37].
To demonstrate that the growth arrest effects seen for the
constitutively active Ste2 - Fz 1/2 receptor chimeras are
a consequence of mating pathway activation we have used
a genetic approach: Deletion of the cyclin-dependent kinase
inhibitor FAR1 partially reversed the growth arrest phenotypes.
Partial reversal was expected, as there are FAR1 - CLN2
independent parallel pathways to mediate growth arrest in wild
type yeast cells [14].
Coupling of Frizzled receptors to the yeast mating pathway
parallels earlier observations with several mammalian GPCRs
expressed in this organism [38,39]. Receptors coupling to various
mammalian G proteins (Gs-, Gi and Gq) could be functionally
expressed, suggesting a considerable degree of evolutionary
conservation at the GPCR - Ga-protein interface. However,
attempts to clearly define GPCR - elements of the primary or
secondary structure responsible for Ga-coupling specificity have
not been successful. This phenomenon is particularly well
illustrated by the yeast Ste2 and Ste3 receptors: Despite low
sequence identity (11%), both couple to the same Ga protein,
Gpa1p. Among the four mammalian Ga - subfamilies the Gi-
subfamily shares the closest sequence similarity with yeast Gpa1p.
This subfamily encompasses Go and Gt, which have been
proposed previously to be involved in Frizzled 1 and Frizzled 2
signaling, respectively ([25,26], and [22,27,28]).
In summary, our report demonstrates that human Frizzled
receptors can signal to the mating pathway in yeast, and this
coupling can be made particulary efficient by introducing
intracellular sequence elements of the Ste2 mating factor receptor
into the Frizzled backbone. This experimental system may prove
useful for the identification and characterization of modulators of
individual Frizzled receptors.
MATERIAL AND METHODS
E. coli and S. cerevisiae strains
All plasmid constructions and amplifications were performed using
the E. coli strains XL1-Blue (Stratagene) or TOP10 (Invitrogen).
For the expression growth test of the Ura3p fusion proteins (Fz1-
Ura3p and s-Fz1-Ura3p, see below) yeast strain JD53 MATa his3-
D200 leu2-3,112 lys2-801 trp1-D63 ura3-52 was used [40]. For
confocal microscopy and Western blot analysis the yeast strain
MH272-1da MATa his3 leu2-3,112 ura3-52 trp1 rme1 HMLa; [41])
was used. For the growth modulation assays MH272-1da and
respective isogenic strains MH272-1da ste2::hphMX4 and MH272-
1da far1::hphMX4 were used (this study, see below). The mating
pathway activation PFUS1-luciferase assays were carried out using
the MC18 ste2::hphMX4 sst2::kanMX4 strain (this study, see below),
a descendant of the previously described strain MC18 MATa
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100; [19].
MH272-1da ste2::hphMX4: The hygromycin phopsphotransfer-
ase disruption cassette was amplified by PCR using the STE2-
targeting primers: DD_46 (59-GCTCTGGCTATAATTATAA-
TTGGTTACTTAAAAATGCACCGTTAAGAACCATATCC-
AAGAATCCAGCTGAAGCTTCGTACGCTGCAGG-39) and
DD_47 (59-CTAGTAGTAACCTTATACCGAAGGTCACGA-
AATTACTTTTTCAAAGCCGTAAATTTTGGCCGCATAG-
GCCACTAGTGGATCTG-39). These primers were derived
from the plasmid construct pAG32 [42]. The resulting PCR-
product was used to transform the MH272-1da strain that was
plated onto YPD plates containing 300 mgm L
21 hygromycin B
(Sigma). Correct integration of the cassette into the STE2 locus
was verified by colony-PCR using primers DD_42 (59-CTGC-
TTAGGACCTGTGCCTGGA-39) and DD_43 (59-GCTTGAA-
CTCGTAAAAGCAAAG-39) flanking the Ste2p coding sequence.
Following cloning of the PCR product into pCR4-TOPO
(Invitrogen), sequencing confirmed the correct integration.
MH272-1da far1::hphMX4: The hygromycin phopsphotransfer-
ase disruption cassette was amplified by PCR using the FAR1-
targeting primers: DD_84 (59-CCTTTACACAAAGTCTATAG-
ATCCACTGGAAAGCTTCGTGGGCGTAAGAAGGCAATC-
TATTACAGCTGAAGCTTCGTACGCTGCAGG-39) and
DD_87 (59-CACCCGCAGCCATATCCCCCAAATATACTT-
GCTCGAATGTAGCTTGTGGTAGACGAAGAGGCCGCA-
TAGGCCACTAGTGGATCTG-39). These primers were derived
from the plasmid constructpAG32[42]. The resulting PCR-product
was used to transform the MH272-1da strain that was plated onto
YPD plates containing 300 mgm L
21 hygromycin B (Sigma).
Correct integration of the cassette into the FAR1 locus was verified
by colony-PCR using primers DD_86 (59-gttcactctgtcttgagagtg-39),
priming in the 59 UTR of the FAR1 locus, and DD_72 (59-
ccatggcctccgcgaccgg-39) priming in the disruption cassette. Follow-
ing cloning of the PCR product into pCR4-TOPO (Invitrogen),
sequencing confirmed the correct integration.
MC18 ste2::hphMX4 sst2::kanMX4: The targeted disruptions of
STE2 and SST2 genes were performed sequentially as follows. The
disruption of STE2 was performed as described for MH272-1da
ste2::hphMX4 except that MC18 was employed as parent strain.
The resulting strain was termed MC18 ste2::hphMX4. For
subsequent disruption of SST2, the kanamycin resistance disrup-
tion cassette was amplified by PCR using primers DD_68 (59-
GTTTTGCACGCACTATCTGAGGCGTTATAGGTTCAAT-
TTGGTAATTAAAGATAGAGTTGTAAGCAGCTGAAGCT-
TCGTACGCTGCAGG-39) and DD_69 (59-CTAAAGAAAAA-
AAAAAGGACTGTTTGTGCAATTGTACCTGAAGATGAG-
TAAGACTCTCAATGGCCGCATAGGCCACTAGTGGATC-
TG-39) derived from pFA6a-kanMX4 [43]. The resulting PCR-
product was used to transform the MC18 ste2::hphMX4 strain that
was plated onto YPD plates containing 300 mgm L
21 hygromycin
B (Sigma) and 200 mgm L
21 geneticin (Invitrogen).
Correct integration of the cassette into the SST2 locus was
verified by colony-PCR using primers DD_70 (59-GTCTTTA-
CTTCTCATCGTCC-39), priming in the 59 UTR of the SST2
locus, and DD_71 (59-GCGCATCGGGCTTCCCATAC-39)
priming in the disruption cassette. Following cloning of the PCR
product into pCR4-TOPO (Invitrogen), sequencing confirmed the
correct integration. The resulting strain was termed MC18
ste2::hphMX4 sst2::kanMX4.
Plasmid constructs
Correctness of all constructs was determined using sequencing.
Below described constructs pPCUP1-Fz1-CRU and pPCUP1-s-Fz1-
CRU are derived from a parallel study to search for protein-
protein interactions of the Frizzled 1 receptor using the Ura3p-
based yeast split-ubiquitin interaction system [44] that will be
published separately (Dirnberger D. and Baumeister R., Univer-
sity of Freiburg, Germany; manuscript in preparation).
pPCUP1-Fz1-CRU: This construct is based on the previously
described vector pPCUP1-ubc9-CRU [45], which is a low copy
yeast - E. coli shuttle vector that carries a Cub-R-URA3 cassette
(CRU), a copper-dependent promoter (PCUP1) for bait expression,
and a HIS3 marker. The human Frizzled 1 coding sequence was
amplified by PCR from a human whole brain cDNA preparation
(Clontech) using primers Fz1-FW (59-AATTGTCGACATGGC-
TGAGGAGGAGGCGCCTAAG-39) and Fz1-RV (59-AGCG-
GCCGCGACTGTAGTCTCCCCTTGTTTGC-39), introduc-
ing SalI and NotI restriction sites, respectively. The Fz1 PCR
product was eventually used to replace the Ubc9 insert in pPCUP1-
ubc9-CRU using SalI-NotI restriction sites, resulting in pPCUP1-
Fz1-CRU.
pPCUP1-s-Fz1-CRU: The 59 138 basepairs of the Saccharomyces
cerevisiae STE2 coding sequence, comprising the receptor’s
complete N-terminal extracellular tail, were amplified from a yeast
genomic DNA preparation using primers Ste2-FW (59-AAT-
TGTCGACATGTCTGATGCGGCTCCTTC-39), introducing
SalI, and Ste2-RV (59-GTACTGTTAACTAAACCTTG-39), in-
troducing a HpaI site. Human Fz1 cDNA lacking the 59 333
basepairs of the coding sequence, comprising the region upstream
of the receptor’s cysteine rich domain (CRD), was amplified from
pPCUP1-Fz1-CRU using primers Fz1-HpaI (59-ATATGTTAAC-
GACCACGGCTATTGCCAGCC-39), introducing HpaI, and
Fz1-RV. In a triple ligation set up, SalI-HpaI restricted Ste2
fragment and HpaI-NotI restricted Fz1 fragment were used to
replace the ubc9 insert in pPCUP1-ubc9-CRU using SalI-NotI
restriction sites, resulting in pPCUP1-s-Fz1-CRU.
pYES2-s-Fz1-myc: The s-Fz1 fusion gene was amplified by
PCR from pPCUP1-s-Fz1-CRU using primers DD_11 (59-ATAA-
GCTTATGGCTGAGGAGGAGGCGCC-39) and DD_12 (59-
TAGGATCCCTACAGATCCTCTTCTGAGATGAGTTTTT-
GTTCGACTGTAGTCTCCCCTTGTTTG-39), introducing
a HindIII site, a C-terminal c-myc-tag followed by a STOP codon,
and a BamHI site, respectively. The HindIII-BamHI digested s-Fz1-
myc fragment was ligated to HindIII-BamHI restricted yeast
expression vector pYES2 (Invitrogen), resulting in pYES2-s-Fz1-
myc.
pYES2-s-Fz1-GFP: The s-Fz1 fusion gene was amplified by
PCR from pPCUP1-s-Fz1-CRU using primers DD_13 (59-
ATAAGCTTATGTCTGATGCGGCTCCTTCATTG-39) and
DD_18 (59-TAGAATTCGACTGTAGTCTCCCCTTGTTTG-
39) introducing HindIII and EcoRI sites, respectively. Enhanced
green fluorescent protein (eGFP) was amplified by PCR from
pEGFP-C1 (Clontech) using primers DD_19 (59-ATGAATTC-
GTGAGCAAGGGCGAGGAGC-39) and DD_20 (59-TAGGA-
TCCTTACTTGTACAGCTCGTCCATGC-39), introducing
EcoRI and BamHI sites, respectively. HindIII-EcoRI digested s-Fz1
and EcoRI-BamHI digested eGFP fragments were ligated to
HindIII-BamHI restricted yeast expression vector pYES2 (Invitro-
gen), resulting in pYES2-s-Fz1-GFP.
pYES2-s-Fz2-myc: In order to be able to replace the Fz1 HpaI-
EcoRI fragment from pYES2-s-Fz1-myc with the respective Fz2
fragment, the second HpaI site within the pYES2 vector backbone
was first eliminated using GeneTailorTM (Invitrogen) site-directed
mutagenesis kit with primers DD_36 (59-CACTTCAATAGCA-
TATCTTTGTAAACGAAGCATCTG-39) and DD_37 (59-AAA-
GATATGCTATTGAAGTGCAAGATGGAAAC-39). Human
Fz2 cDNA lacking the 59 102 basepairs of the coding sequence,
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domain (CRD), was amplified from a Fz2 IMAGE clone (Thomas
Schlange, Friedrich Miescher Institute, Basel) using primers
DD_38 (59-TATCGTTAACGACCACGGCTTCTGCCAGCC-
39), introducing HpaI, and DD_39 (59-GTAGAATTCCTACA-
GATCCTCTTCTGAGATGAGTTTTTGTTCCACGGTGGT-
CTCACCGTGTCGGCTGTTG-39), introducing a C-terminal c-
myc tag followed by a stop-codon, and an EcoRI site. The
HpaI-EcoRI - restricted Fz2 fragment was used to replace the Fz1
HpaI-EcoRI fragment from pYES2-s-Fz1-myc, resulting in
pYES2-s-Fz2-myc.
pYES2-Ste2-Fz1(i), pYES2-Ste2-Fz2(i), pYES2-s-Fz1-Ste2(i)
and pYES2-s-Fz2-Ste2(i): Fully synthetic genes for the receptor
chimeras between Ste2 and human Frizzled1 or Frizzled2 with
sequences as shown in the Supporting Information section were
ordered at GENEART AG (Regensburg, Germany; Text S1). All
sequences were optimized for expression in yeast by adapting to
the yeast codon-usage, contained a C-terminal c-myc-tag, and
HindIII-EcoRI sites for subcloning into pYES2.
pYES2-Ste2-Fz1(i)-GFP and pYES2-s-Fz1-Ste2(i)-GFP: The
Ste2-Fz1(i) and s-Fz1-Ste2(i) synthetic genes were amplified by
PCR using primers DD_13 (59-ATAAGCTTATGTCTGATG-
CGGCTCCTTCATTG-39) and DD_63 (59-ATGAATTCCAA-
ATCCTCTTCAGAAATCAATTTTTGTTC-39) introducing
HindIII and EcoRI sites, respectively. Enhanced green fluorescent
protein (eGFP) was amplified by PCR from pEGFP-C1 (Clontech)
using primers DD_19 (59-ATGAATTCGTGAGCAAGGGC-
GAGGAGC-39) and DD_20 (59-TAGGATCCTTACTTGTA-
CAGCTCGTCCATGC-39), introducing EcoRI and BamHI sites,
respectively. HindIII-EcoRI digested Ste2-Fz1(i) or s-Fz1-Ste2(i) and
EcoRI-BamHI digested eGFP fragments were ligated to HindIII-
BamHI restricted yeast expression vector pYES2, resulting in
pYES-Ste2-Fz1(i)-GFP and pYES2-s-Fz1-Ste2(i)-GFP.
pYES2-Ste2-myc: The Ste2 coding sequence was amplified by
PCR from a yeast genomic DNA preparation using primers
DD_55 (59-TAAAGCTTAAAAATGTCTGATGCGGCTCCT-
TC-39) and DD_56 (59-GTAGAATTCCTACAGATCCTCTT-
CTGAGATGAGTTTTTGTTCTAAATTATTATTATCTTC-
AGTCC-39), introducing a HindIII, and a C-terminal c-myc tag,
followed by a STOP codon and a EcoRI site, respectively. The
HindIII-EcoRI digested PCR fragment was ligated to HindIII-EcoRI
digested pYES2, resulting in pYES2-Ste2-myc.
pYES2-Edg2-myc: The human Edg2 coding sequence was
amplified by PCR from pcDNA3.1TOPOV hEDG2 (S. Marrony,
Novartis) using primers DD_9 (59-ATAAGCTTATGGCTGC-
CATCTCTACTTC-39) and DD_10 (59-TAGGATCCCTACA-
GATCCTCTTCTGAGATGAGTTTTTGTTCAACCACAGA-
GTGGTCATTGCTG-39), introducing a HindIII, and a C-
terminal c-myc tag, followed by a STOP codon and a BamHI
site, respectively. The HindIII-BamHI digested PCR fragment was
ligated to HindIII-BamHI digested pYES2, resulting in pYES2-
Edg2-myc.
Yeast methodologies
Standard yeast methodologies were used as described in [46]. For
yeast transformations the LiAc/carrier DNA/PEG method was
employed [47].
Expression growth test for Fz1- and s-Fz1 - Ura3p
fusion proteins
Yeast strain JD53 [38] was transformed with pPCUP1-Fz1-CRU or
pYES2-s-Fz1-myc, and plated equally onto SD-HIS, and SD-HIS-
URA minimal media plates containing Cu2SO4 (100 mM) as
inducer of protein expression.
Growth modulation assays upon receptor
overexpression on solid medium
Yeast strain MH272-1da or MH272-1da far1::hphMX4 were
transformed each with equal amounts of plasmid DNA of receptor
expression constructs as indicated in the results section, and plated
onto SD-URA minimal medium agar plates. Resulting single
clones were inoculated into liquid SD-URA minimal medium, and
incubated over night. Yeast cultures were spotted in serial dilutions
(,1E4, 1E3, 1E2 cells per spot) onto SD-URA (glucose contain-
ing) and SD+galactose-URA agar plates, and incubated as
indicated in the results section.
Growth modulation assays upon receptor
overexpression in liquid medium, and budding
index determinations
Yeast strain MH272-1da transformed with plasmid DNA of
receptor expression constructs as indicated in the results section
was grown in SD-URA medium (glucose containing). Growth of
exponentially growing cultures was monitored using optical
density determination (OD 600 nm) as measured in a BIOTEK
Synergy HT plate reader. Aliquots of the exponentially growing
cultures in SD-URA were pelleted using centrifugation and
washed twice with, and finally resuspended in, SD+galactose-
URA medium. The budding index of each culture was calculated
as ratio of number of budded cells to total cells as determined
using a hemocytometer slide at the indicated timepoints over
32 hours.
Mating pathway activation growth assay on solid
medium
Yeast strains MH272-1da, MH272-1da far1::hphMX4 and
MH272-1da ste2::hphMX4 were incubated over night in SD
complete minimal medium (SDC), and were spotted in serial
dilutions (,1E4, 1E3, 1E2 cells per spot) onto SDC agar plates in
duplicates. 1 mg a-factor (Sigma) was used to treat one dilution
series of each strain by spotting directly onto the yeast patches.
Mating pathway activation PFUS1-luciferase assays
The PFUS1-firefly luciferase reporter system was described pre-
viously [21], and was used here with the following modifications
for two different assay modes. For both modes, the newly devised
yeast strain MC18 ste2::hphMX4 sst2::kanMX4 was employed. The
strain was sequentially co-transformed with pRHF-luc (carrying
the PFUS1-luciferase reporter module), pRGP-Gpa1 (for Gpa1
expression under its native promoter from a low copy plasmid;
[19]) or the respective empty parent plasmid pRS413 [48], and the
pYES2-based receptor expression constructs as indicated in the
results section. Plating was done onto repressive SD-TRP-URA-
HIS minimal medium.
One assay mode was particularly devised for strain-to-strain
comparisons of the basal PFUS1-luciferase levels: Single clones were
inoculated into 10 mL SD-TRP-URA-HIS medium and in-
cubated over night. Subsequently, the culture was divided 1:1,
cells were pelleted, washed twice with 10 mL sterile water,
resuspended in 5 mL SD-TRP-URA-HIS medium, or inducing
5m LS D +galactose-TRP-URA-HIS medium, and incubated for 6
or 24 hours at 30uC (as indicated in the results section). Cells were
pelleted again and washed with 10 mL water. The pellet was
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supplemented with a protease inhibitor cocktail (1 complete
miniTM protease inhibitory tablet from Roche per 50 mL PBS).
Acid-washed glass beads (0.45 mm, Sigma) corresponding to
a volume of ,200 mL were added, and cells were disrupted using
a swinging mill (Qiagen) at maximal amplitude for 5 minutes. The
resulting crude protein extract was cleared by centrifugation at
3.0006g for 5 minutes at 4uC. 10 mL of the extract were assayed
in a total volume of 100 mL PBS (including protease inhibitor
cocktail) in duplicates for luciferase activity using a BIOTEK
Synergy HT device to inject 100 mL of luciferase assay reagent
(Promega) in 96-well format. The luciferase levels were normalized
to total protein content as determined using the Biorad protein
assay.
The second assay mode was used for the ligand concentration-
response experiments, and represents a simplified assay procedure
for increased throughput. Single clones were inoculated into
50 mL SD-TRP-URA-HIS medium and incubated to exponential
growth phase. Subsequently, cells were pelleted, washed twice with
50 mL sterile water, and resuspended in inducing 50 mL
SD+galactose-TRP-URA-HIS, and incubated for 4 hours at
30uC to allow for receptor expression. Subsequently, the optical
density (OD600nm) of the culture was adjusted to 0.2–0.4 as
measured in a BIOTEK Synergy HT plate reader. 500 mL
aliquots of the culture were prepared in a 24-well cell culture plate
(TPP, Switzerland), and treated with a-factor (Sigma), recombi-
nant carrier-free mouse Wnt-3a or Wnt-5a (R&D Systems) as
indicated in the results section for 4 hours at 30uC. For a removal
of the medium, the aliquots were transferred to 2 mL Spin-XH
centrifuge tube cellulose acetate filters (Corning Costar), and
centrifuged at 3.0006g for 1 minute. The cells were resuspended
in 500 mL deionized water, and 100 mL aliquots were arrayed in
quadruplets in a transparent flat-bottom 96-well plate (Nunc). OD-
measurement of the plate was performed optionally to control
proper pipetting. From this step on, all subsequent pipetting steps
were performed using a multi-channel pipette. The cell wall was
digested for 30 minutes at 37uC by adding 50 mL of zymolyase
100T (SEIKAGAKU) stock solution in water (40 mg mL
21)
supplemented with a protease inhibitor cocktail (1 complete
miniTM protease inhibitory tablet from Roche per 50 mL
solution). Eventually, 50 mL tissue-culture luciferase-assay lysis
buffer (Sigma) was used to disintegrate the cells by repeated up-
and-down pipetting. Finally, 50 mL aliquots were assayed for
luciferase-activity as described above.
Western blot analysis
Yeast strain MH272-1da [41] transformed with constructs as
indicated in the result section was cultivated in 50 mL SD-URA
medium to the exponential growth phase. To induce protein
expression, the cultures were transferred to galactose-containing
full medium (YPGal) for 6 hours. Cells were pelleted, and
resuspended in 300 mL lysis buffer (100 mM Tris-HCl pH 8.0,
20% glycerol, 1% Triton X-100, 1 mM dithiothreitol, 1 mM
phenylmethylsulphonylfluoride). Cells were disrupted by vortexing
at 4uC for 10 minutes following addition of acid-washed glass
beads (0.45 mm diameter). The crude protein extract was cleared
by centrifugation at 30006g for 5 minutes. The protein
concentration was determined using the Biorad protein assay.
20 mg extract were electrophoresed using a 4–12% gradient
NuPAGE Bis-Tris gel system (Invitrogen). The proteins were
electroblotted to a nitrocellulose membrane. Anti-c-myc detection
using a monoclonal antibody from Roche (clone 9E10) was
performed either through enhanced chemiluminescence (Biorad
Immun-Star HRP substrate kit; and Hyperfilm from Amersham
Biosciences) or chromogenic detection (Invitrogen Western Breeze
kit). As loading control, a rabbit anti-Kss1p polyclonal antibody
(Santa Cruz) was used at 1:200 dilution, and detected using the
Invitrogen Western Breeze kit.
Confocal microscopy
Microscopic inspections of agarose-embedded galactose-induced s-
Fz1-GFP, Ste2-Fz1(i)-GFP or s-Fz1-Ste2(i)-GFP expressing yeast
strain MH272-1da were performed using a Zeiss LSM510
confocal microscope.
SUPPORTING INFORMATION
Text S1
Found at: doi:10.1371/journal.pone.0000954.s001 (0.03 MB
DOC)
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